|
1
|
Loibl S, Poortmans P, Morrow M, Denkert C
and Curigliano G: Breast cancer. Lancet. 397:1750–1769.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhou J, Su CM, Chen HA, Du S, Li CW, Wu H,
Tsai SH and Yeh YT: Cryptanshinone inhibits the glycolysis and
inhibits cell migration through PKM2/β-catenin axis in breast
cancer. Onco Targets Ther. 13:8629–8639. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mao YJ, Lim HJ, Ni M, Yan WH, Wong DW and
Cheung JC: Breast tumour classification using ultrasound
elastography with machine learning: A systematic scoping review.
Cancers (Basel). 14(367)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yankaskas CL, Thompson KN, Paul CD, Vitolo
MI, Mistriotis P, Mahendra A, Bajpai VK, Shea DJ, Manto KM, Chai
AC, et al: A microfluidic assay for the quantification of the
metastatic propensity of breast cancer specimens. Nat Biomed Eng.
3:452–465. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Roychowdhury S, McCullough RL, Sanz-Garcia
C, Saikia P, Alkhouri N, Matloob A, Pollard KA, McMullen MR,
Croniger CM and Nagy LE: Receptor interacting protein 3 protects
mice from high-fat diet-induced liver injury. Hepatology.
64:1518–1533. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kaczmarek A, Vandenabeele P and Krysko DV:
Necroptosis: The release of damage-associated molecular patterns
and its physiological relevance. Immunity. 38:209–223.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan
K, Cheng H, Jin K, Ni Q, Yu X and Liu C: The role of necroptosis in
cancer biology and therapy. Mol Cancer. 18(100)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Daniels BP, Kofman SB, Smith JR, Norris
GT, Snyder AG, Kolb JP, Gao X, Locasale JW, Martinez J, Gale M Jr,
et al: The nucleotide sensor ZBP1 and kinase RIPK3 induce the
enzyme iRG1 to promote an antiviral metabolic state in neurons.
Immunity. 50:64–76.e4. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Park JE, Lee JH, Lee SY, Hong MJ, Choi JE,
Park S, Jeong JY, Lee EB, Choi SH, Lee YH, et al: Expression of key
regulatory genes in necroptosis and its effect on the prognosis in
non-small cell lung cancer. J Cancer. 11:5503–5510. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li X, Guo J, Ding AP, Qi WW, Zhang PH, Lv
J, Qiu WS and Sun ZQ: Association of mixed lineage kinase
domain-like protein expression with prognosis in patients with
colon cancer. Technol Cancer Res Treat. 16:428–434. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Höckendorf U, Yabal M, Herold T,
Munkhbaatar E, Rott S, Jilg S, Kauschinger J, Magnani G, Reisinger
F, Heuser M, et al: RIPK3 restricts myeloid leukemogenesis by
promoting cell death and differentiation of leukemia initiating
cells. Cancer Cell. 30:75–91. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jiao D, Cai Z, Choksi S, Ma D, Choe M,
Kwon HJ, Baik JY, Rowan BG, Liu C and Liu ZG: Necroptosis of tumor
cells leads to tumor necrosis and promotes tumor metastasis. Cell
Res. 28:868–870. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
He X, Feng Z, Ma J, Ling S, Cao Y, Gurung
B, Wu Y, Katona BW, O'Dwyer KP, Siegel DL, et al: Bispecific and
split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid
leukemia. Blood. 135:713–723. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu Y, Kyle-Cezar F, Woolf RT,
Naceur-Lombardelli C, Owen J, Biswas D, Lorenc A, Vantourout P,
Gazinska P, Grigoriadis A, et al: An innate-like Vδ1+ γδ
T cell compartment in the human breast is associated with remission
in triple-negative breast cancer. Sci Transl Med.
11(eaax9364)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Snyder AG, Hubbard NW, Messmer MN, Kofman
SB, Hagan CE, Orozco SL, Chiang K, Daniels BP, Baker D and Oberst
A: Intratumoral activation of the necroptotic pathway components
RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol.
4(eaaw2004)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chung W, Eum HH, Lee HO, Lee KM, Lee HB,
Kim KT, Ryu HS, Kim S, Lee JE, Park YH, et al: Single-cell RNA-seq
enables comprehensive tumour and immune cell profiling in primary
breast cancer. Nat Commun. 8(15081)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zou Y, Ye F, Kong Y, Hu X, Deng X, Xie J,
Song C, Ou X, Wu S and Wu L: The single-cell landscape of
intratumoral heterogeneity and the immunosuppressive
microenvironment in liver and brain metastases of breast cancer.
Adv Sci (Weinh). 10(e2203699)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fu X, Wu X, Djekidel MN and Zhang Y: Myc
and Dnmt1 impede the pluripotent to totipotent state transition in
embryonic stem cells. Nat Cell Biol. 21:835–844. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shigemizu D, Iwase T, Yoshimoto M, Suzuki
Y, Miya F, Boroevich KA, Katagiri T, Zembutsu H and Tsunoda T: The
prediction models for postoperative overall survival and
disease-free survival in patients with breast cancer. Cancer Med.
6:1627–1638. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Feng H, Zhong L, Yang X, Wan Q, Pei X and
Wang J: Development and validation of prognostic index based on
autophagy-related genes in patient with head and neck squamous cell
carcinoma. Cell Death Discov. 6(59)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu D, Liu X, Wang Y, Zhou K, Wu J, Chen
JC, Chen C, Chen L and Zheng J: Identification of immune subtypes
and prognosis of hepatocellular carcinoma based on immune
checkpoint gene expression profile. Biomed Pharmacother.
126(109903)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu D, Schilling B, Liu D, Sucker A,
Livingstone E, Jerby-Arnon L, Zimmer L, Gutzmer R, Satzger I,
Loquai C, et al: Integrative molecular and clinical modeling of
clinical outcomes to PD1 blockade in patients with metastatic
melanoma. Nat Med. 25:1916–1927. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ru B, Wong CN, Tong Y, Zhong JY, Zhong
SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, et al: TISIDB: An
integrated repository portal for tumor-immune system interactions.
Bioinformatics. 35:4200–4202. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nguyen VC, Nguyen TQ, Vu TNH, Phung TH,
Nguyen TPH, Nguyen ND and Le DR: Application of St Gallen
categories in predicting survival for patients with breast cancer
in Vietnam. Cancer Control. 26(1073274819862794)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xie J, Deng W, Deng X, Liang JY, Tang Y,
Huang J, Tang H, Zou Y, Zhou H and Xie X: Single-cell histone
chaperones patterns guide intercellular communication of tumor
microenvironment that contribute to breast cancer metastases.
Cancer Cell Int. 23(311)2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gao W, Wang X, Zhou Y, Wang X and Yu Y:
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor
immunotherapy. Signal Transduct Target Ther. 7(196)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li X, Chen M, Shi Q, Zhang H and Xu S:
Hydrogen sulfide exposure induces apoptosis and necroptosis through
lncRNA3037/miR-15a/BCL2-A20 signaling in broiler trachea. Sci Total
Environ. 699(134296)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dawson SJ, Makretsov N, Blows FM, Driver
KE, Provenzano E, Le Quesne J, Baglietto L, Severi G, Giles GG,
McLean CA, et al: BCL2 in breast cancer: A favourable prognostic
marker across molecular subtypes and independent of adjuvant
therapy received. Br J Cancer. 103:668–675. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang L, Lu Z and Zhao X: Targeting Bcl-2
for cancer therapy. Biochim Biophys Acta Rev Cancer.
1876(188569)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lok SW, Whittle JR, Vaillant F, Teh CE, Lo
LL, Policheni AN, Bergin ART, Desai J, Ftouni S, Gandolfo LC, et
al: A phase Ib dose-escalation and expansion study of the BCL2
inhibitor venetoclax combined with tamoxifen in ER and
BCL2-positive metastatic breast cancer. Cancer Discov. 9:354–369.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Frazzi R: BIRC3 and BIRC5: Multi-faceted
inhibitors in cancer. Cell Biosci. 11(8)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhou Q, Xu Y, Shen L, Yang X and Wang L:
Identification of a novel necroptosis-related classifier to predict
prognosis and guide immunotherapy in breast invasive carcinoma.
Front Oncol. 12(852365)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zaidi MR: The interferon-gamma paradox in
cancer. J Interferon Cytokine Res. 39:30–38. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wu ZH, Tang Y, Yu H and Li HD: The role of
ferroptosis in breast cancer patients: A comprehensive analysis.
Cell Death Discov. 7(93)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rotman J, den Otter LAS, Bleeker MCG,
Samuels SS, Heeren AM, Roemer MGM, Kenter GG, Zijlmans HJMAA, van
Trommel NE, de Gruijl TD and Jordanova ES: PD-L1 and PD-L2
expression in cervical cancer: Regulation and biomarker potential.
Front Immunol. 11(596825)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zou R, Zhao W, Xiao S and Lu Y: A
signature of three apoptosis-related genes predicts overall
survival in breast cancer. Front Surg. 9(863035)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhang Y, Yang Y, Liu R, Meng Y, Tian G and
Cao Q: Downregulation of microRNA-425-5p suppresses cervical cancer
tumorigenesis by targeting AIFM1. Exp Ther Med. 17:4032–4038.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fang Y, Liu J, Zhang Q, She C, Zheng R,
Zhang R, Chen Z, Chen C and Wu J: Overexpressed VDAC1 in breast
cancer as a novel prognostic biomarker and correlates with immune
infiltrates. World J Surg Oncol. 20(211)2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu Z and Chan FK: Regulatory mechanisms
of RIPK1 in cell death and inflammation. Semin Cell Dev Biol.
109:70–75. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kwok C, Pavlosky A, Lian D, Jiang J, Huang
X, Yin Z, Liu W, Haig A, Jevnikar AM and Zhang ZX: Necroptosis is
involved in CD4+ T cell-mediated microvascular endothelial cell
death and chronic cardiac allograft rejection. Transplantation.
101:2026–2037. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhang Z, Li J, He T and Ding J:
Bioinformatics identified 17 immune genes as prognostic biomarkers
for breast cancer: Application study based on artificial
intelligence algorithms. Front Oncol. 10(330)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tekpli X, Lien T, Røssevold AH, Nebdal D,
Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M,
Due EU, et al: An independent poor-prognosis subtype of breast
cancer defined by a distinct tumor immune microenvironment. Nat
Commun. 10(5499)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Shi W, Chen Z, Liu H, Miao C, Feng R, Wang
G, Chen G, Chen Z, Fan P, Pang W and Li C: COL11A1 as an novel
biomarker for breast cancer with machine learning and
immunohistochemistry validation. Front Immunol.
13(937125)2022.PubMed/NCBI View Article : Google Scholar
|
